Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-25-000266·Applied Therapeutics, Inc.
Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock · CUSIP: 03828A101
Event date: 2025-01-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 2,858,931 · Class: 2.5%
- Morgan Stanley Capital Services LLC
Shares: 2,667,759 · Class: 2.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000266
- Form type
- SCHEDULE 13G/A
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Feb 07, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership